StemCells, Inc.

7707 Gateway Blvd Ste 140 , Newark, CA 94560

Public
Healthcare & Pharmaceuticals - Biotechnology
around $10 - 20M
around 100 - 250
(510) 456-4000
(510) 456-4001
irpr@stemcellsinc.com


StemCells, Inc. (StemCells) is engaged in the research, development and commercialization of stem cell therapeutics. The Company is focused on developing and commercializing stem and progenitor cells as the basis for therapeutics and therapies. Its lead product development program is its central nervous system (CNS) program, in which it is developing applications for HuCNS-SC cells, its human neural platform technology. It is in clinical development with its HuCNS-SC cells for a range of diseases and disorders of the central nervous system, which consists of the brain, spinal cord and eye. It is conducting a Phase I/II clinical trial to evaluate the safety and preliminary efficacy of its HuCNS-SC cells as a treatment for dry age-related macular degeneration (AMD). It has conducted a Radian... (Source: SEC reports)


Competitor - 1/7
Which company is more competitive with StemCells, Inc.?


16 Contacts at this company
Stephen Huhn, MD
VP, Clinical Research and Chief Medical
Karl Eckert
Project Coordinator
Cindy Hayashi
Executive Director of Human Resources ...
Alexander Winans
Research And Development Scientist ...
Greg Schiffman
Director
Geetanjali Kabra, CPA
Accounting Manager
Thorsten Gorba
Translating Center Director, IQVIA Stem ...
holly huntington
Director, Clinical Trial Operations
Naymisha Patel
Vice President, Quality

No company news available.
Get Started Today : Sign up in 20 seconds
Search with 20+ criteria.
Export results in seconds.
Bad emails?
No worry, we give two extras for every bad email.